Clinical RoundupFree Mouse model study shows promise in treatment of medulloblastoma and ependymoma May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA approves GSK’s PARP inhibitor Zejula for first-line maintenance of advanced ovarian cancer May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants accelerated approval to new dosing regimen for Keytruda May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants Mobocertinib Breakthrough Therapy Designation in NSCLC designation May 01, 2020Vol.46 No.18
FreeIn Brief Kristin Brill named enterprise director of Breast Oncology at SKCC May 01, 2020Vol.46 No.18
FreeIn Brief UCLA researchers receive $2.8M NCI grant to develop blood-based test for liver transplant candidate selection May 01, 2020Vol.46 No.18
COVID-19 UpdatesFree FDA grants Emergency Use Authorization for novel, non-implanted device to wean patients off mechanical ventilation May 01, 2020Vol.46 No.18
